Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 55.14 USD -1.47% Market Closed
Market Cap: 6.5B USD
Have any thoughts about
Cytokinetics Inc?
Write Note

Cytokinetics Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytokinetics Inc
Income from Continuing Operations Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Cytokinetics Inc
NASDAQ:CYTK
Income from Continuing Operations
-$576.4m
CAGR 3-Years
-36%
CAGR 5-Years
-37%
CAGR 10-Years
-43%
Abbvie Inc
NYSE:ABBV
Income from Continuing Operations
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Income from Continuing Operations
$113m
CAGR 3-Years
-75%
CAGR 5-Years
-47%
CAGR 10-Years
-36%
Amgen Inc
NASDAQ:AMGN
Income from Continuing Operations
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Income from Continuing Operations
-$479.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
2%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Income from Continuing Operations
$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
30%

See Also

What is Cytokinetics Inc's Income from Continuing Operations?
Income from Continuing Operations
-576.4m USD

Based on the financial report for Sep 30, 2024, Cytokinetics Inc's Income from Continuing Operations amounts to -576.4m USD.

What is Cytokinetics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-43%

Over the last year, the Income from Continuing Operations growth was -9%. The average annual Income from Continuing Operations growth rates for Cytokinetics Inc have been -36% over the past three years , -37% over the past five years , and -43% over the past ten years .

Back to Top